SAMIR FARAG: Open Payments
NPI 1285648329 · EAGLEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 72 payments from 12 companies in 2025. Trend: 2023 $2,290 · 2024 $1,883 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $242 |
| Otsuka America Pharmaceutical, Inc. | 11 | $227 |
| Vanda Pharmaceuticals Inc. | 7 | $193 |
| Janssen Pharmaceuticals, Inc | 7 | $168 |
| ABBVIE INC. | 15 | $149 |
| E.R. Squibb & Sons, L.L.C. | 7 | $127 |
| Neurocrine BioSciences, Inc. | 5 | $125 |
| Lundbeck LLC | 6 | $110 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
Products named: REXULTI, CAPLYTA, FANAPT, VRAYLAR, COBENFY, INGREZZA, INVEGA SUSTENNA, SPRAVATO.
Industry payments across PA — which companies pay providers there.
